Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 510

The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index.

Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Open access
Haddad, Robert I, Bischoff, Lindsay, Ball, Douglas, Bernet, Victor, Blomain, Erik, Busaidy, Naifa Lamki, Campbell, Michael, Dickson, Paxton, Duh, Quan-Yang, Ehya, Hormoz, Goldner, Whitney S., Guo, Theresa, Haymart, Megan, Holt, Shelby, Hunt, Jason P., Iagaru, Andrei, Kandeel, Fouad, Lamonica, Dominick M., Mandel, Susan, Markovina, Stephanie, McIver, Bryan, Raeburn, Christopher D., Rezaee, Rod, Ridge, John A., Roth, Mara Y., Scheri, Randall P., Shah, Jatin P., Sipos, Jennifer A., Sippel, Rebecca, Sturgeon, Cord, Wang, Thomas N., Wirth, Lori J., Wong, Richard J., Yeh, Michael, Cassara, Carly J., Darlow, Susan·2022·Journal of the National Comprehensive Cancer Network

Abstract

Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine therapy in most patients. Surgery is also the main treatment for medullary thyroid carcinoma, and kinase inhibitors may be appropriate for select patients with recurrent or persistent disease that is not resectable. Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. When systemic therapy is indicated, targeted therapy options are preferred. This article describes NCCN recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, and surgical management of differentiated thyroid carcinoma (papillary, follicular, Hürthle cell carcinoma).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2022.0040

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 148 references

Cited by

See all 510

Metadata

Authors
Haddad, R. I., Bischoff, L., Ball, D., Bernet, V., Blomain, E., Busaidy, N. L., Campbell, M., Dickson, P., Duh, Q.-Y., Ehya, H., Goldner, W. S., Guo, T., Haymart, M., Holt, S., Hunt, J. P., Iagaru, A., Kandeel, F., Lamonica, D. M., Mandel, S., Markovina, S., McIver, B., Raeburn, C. D., Rezaee, R., Ridge, J. A., Roth, M. Y., Scheri, R. P., Shah, J. P., Sipos, J. A., Sippel, R., Sturgeon, C., Wang, T. N., Wirth, L. J., Wong, R. J., Yeh, M., Cassara, C. J., & Darlow, S.
Venue
Journal of the National Comprehensive Cancer Network
Published
2022-08
Volume
20
Issue
8
Pages
925-951
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W4291019388
Cited by
510
References
148
FWCI
62.49
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. https://app.cochat.ai/papers/10.6004/jnccn.2022.0040
The paper
Haddad, R. I., Bischoff, L., Ball, D., Bernet, V., Blomain, E., Busaidy, N. L., Campbell, M., Dickson, P., Duh, Q.-Y., Ehya, H., Goldner, W. S., Guo, T., Haymart, M., Holt, S., Hunt, J. P., Iagaru, A., Kandeel, F., Lamonica, D. M., Mandel, S., . . . Darlow, S. (2022). Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2022.0040

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.